Marshall Wace, LLP Catalent, Inc. Transaction History

Marshall Wace, LLP

$63.3 Billion
Q1 2024

A detailed history of Marshall Wace, LLP transactions in Catalent, Inc. stock. As of the latest transaction made, Marshall Wace, LLP holds 1,706,418 shares of CTLT stock, worth $96 Million. This represents 0.15% of its overall portfolio holdings.

Number of Shares

1,706,418

Previous 1,029,693 65.72%

Holding current value

$96 Million

Previous $46.3 Million 108.21%

% of portfolio

0.15%

Previous 0.08%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	BUY	$42.56 - $59.82 $28.8 Million - $40.5 Million	676,725 Added 65.72%	1,706,418 $96.3 Million
Q4 2023 Feb 14, 2024	BUY	$32.18 - $46.57 $17.4 Million - $25.2 Million	541,853 Added 111.07%	1,029,693 $46.3 Million
Q3 2023 Nov 14, 2023	BUY	$44.2 - $50.2 $21.6 Million - $24.5 Million	487,840 New	487,840 $22.2 Million
Q1 2023 May 15, 2023	BUY	$45.44 - $74.26 $550,460 - $899,585	12,114 New	12,114 $796,000
Q1 2022 May 16, 2022	SELL	$94.19 - $124.49 $639,267 - $844,913	-6,787 Closed	0 $0

Q4 2021 Feb 14, 2022	SELL	$119.57 - $139.07 $23.6 Million - $27.4 Million	-197,355 Reduced 96.68%	6,787 $868,000
Q2 2021 Aug 13, 2021	BUY	$100.34 - $115.69 $19.1 Million - $22.1 Million	190,811 Added 1431.33%	204,142 $22.1 Million
Q1 2021 May 17, 2021	SELL	$101.51 - $125.27 $61.4 Million - $75.7 Million	-604,577 Reduced 97.84%	13,331 $1.4 Million
Q4 2020 Feb 16, 2021	BUY	$85.88 - $105.36 $9.76 Million - $12 Million	113,645 Added 22.54%	617,908 $64.3 Million
Q3 2020 Nov 16, 2020	BUY	$72.74 - $92.5 $29.7 Million - $37.8 Million	408,949 Added 429.05%	504,263 $43.2 Million
Q2 2020 Aug 13, 2020	BUY	$48.02 - $79.04 $4.58 Million - $7.53 Million	95,314 New	95,314 $6.99 Million
Q1 2020 May 15, 2020	SELL	$36.95 - $62.95 $2.4 Million - $4.09 Million	-64,976 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$47.06 - $56.64 $2.57 Million - $3.09 Million	54,511 Added 520.89%	64,976 $3.66 Million
Q3 2019 Nov 14, 2019	SELL	$47.45 - $58.05 $1.32 Million - $1.61 Million	-27,770 Reduced 72.63%	10,465 $499,000
Q2 2019 Aug 14, 2019	BUY	$39.26 - $54.21 $185,464 - $256,088	4,724 Added 14.1%	38,235 $2.07 Million
Q1 2019 May 14, 2019	SELL	$29.84 - $43.92 $4.42 Million - $6.5 Million	-147,959 Reduced 81.53%	33,511 $1.36 Million
Q4 2018 Feb 14, 2019	SELL	$29.95 - $46.34 $5.97 Million - $9.23 Million	-199,181 Reduced 52.33%	181,470 $5.66 Million
Q3 2018 Nov 14, 2018	BUY	$40.12 - $45.55 $15.3 Million - $17.3 Million	380,651 New	380,651 $17.3 Million

Others Institutions Holding CTLT

# of Institutions

484

Shares Held

172M

Call Options Held

865K

Put Options Held

687K

View Full List

About Catalent, Inc.

Ticker CTLT
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 179,896,000
Market Cap $10.1B
Description
Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...

More about CTLT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Marshall Wace, LLP with notifications on news.

Account

Marshall Wace, LLP Catalent, Inc. Transaction History